This announcement is a separate document:
北京市兰台律师事务所关于黑龙江珍宝岛药业股份有限公司回购注销2023年限制性股票激励计划部分限制性股票的法律意见书
Legal Opinion of Lantai Law Firm, Beijing regarding the repurchase and cancellation of some restricted stocks of Heilongjiang ZBD Pharmaceutical Co., Ltd. under the restricted stock incentive plan in 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated